VHCP Management II’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $25.2M | Sell |
462,903
-250,000
| -35% | -$13.6M | 6.64% | 4 |
|
|
2019
Q3 | $29.7M | Sell |
712,903
-250,000
| -26% | -$10.4M | 11.33% | 2 |
|
|
2019
Q2 | $42.2M | Sell |
962,903
-175,172
| -15% | -$7.67M | 13.29% | 3 |
|
|
2019
Q1 | $58.6M | Hold |
1,138,075
| – | – | 17.14% | 2 |
|
|
2018
Q4 | $42.1M | Sell |
1,138,075
-277,316
| -20% | -$10.3M | 18.07% | 1 |
|
|
2018
Q3 | $53.1M | Hold |
1,415,391
| – | – | 14.19% | 2 |
|
|
2018
Q2 | $55.9M | Buy |
1,415,391
+25,000
| +2% | +$988K | 16.74% | 2 |
|
|
2018
Q1 | $35.8M | Sell |
1,390,391
-328,214
| -19% | -$8.45M | 8.64% | 4 |
|
|
2017
Q4 | $46.4M | Buy |
1,718,605
+54,305
| +3% | +$1.47M | 11.11% | 2 |
|
|
2017
Q3 | $60.8M | Hold |
1,664,300
| – | – | 16.81% | 2 |
|
|
2017
Q2 | $37.9M | Buy |
+1,664,300
| New | +$37.9M | 15.15% | 2 |
|